GC2501 Study Site 100 — Los Angelas, California

GC2501 Study Site 100 is a clinical research site located in Los Angelas, California, United States 90095.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

GC2501 Study Site 100 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Alpha 1 Antitrypsin Deficiency.

Sponsors: Grifols Therapeutics LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Los Angelas

Browse all research sites in California · View every site in Los Angelas

• GSK Investigational Site
• Forest Investigative Site 1248
• Forest Investigative Site 1785
• UCLA Medical Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GC2501 Study Site 100?

GC2501 Study Site 100 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GC2501 Study Site 100 conducted?

GC2501 Study Site 100 has 1 clinical trials on record, with 1 currently active. Their work covers Alpha 1 Antitrypsin Deficiency.

Is GC2501 Study Site 100 accredited by Crixeo Clinical Trials?

GC2501 Study Site 100 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GC2501 Study Site 100?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.